Adaptyv Bio raises $40M series a

◆ Amount

$40M

◆ Announced

27 Aug 2026

◆ Company

◆ Source

◆ The Round

Adaptyv Bio raised $40M in series a funding, announced on 27 August 2026, led by Highland Europe, with participation from Ace Ventures, ByFounders, Y Combinator. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Adaptyv Bio

Adaptyv builds an automated AI-native lab for protein design and testing using cell-free synthesis and robotics, enabling AI agents to autonomously design, test, and learn from proteins at scale. Adaptyv Bio is based in Switzerland and currently at series a stage, operating in Biotech, AI Agents.

◆ Investors

◆ Investing funds on Raise

• Y Combinator

◆ Market context

Y Combinator is profiled on Raise, Fusion42's database of venture funds — where each investor's thesis, cheque size and other tracked backings can be followed. This funding event is a citable node in Fusion42's market graph: it links Adaptyv Bio's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market